Does the media prefer XRAY or COO?

In the previous week, Cooper Companies had 16 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 20 mentions for Cooper Companies and 4 mentions for DENTSPLY SIRONA. Cooper Companies' average media sentiment score of 0.86 beat DENTSPLY SIRONA's score of 0.37 indicating that Cooper Companies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cooper Companies 8 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer XRAY or MMSI?

In the previous week, Merit Medical Systems had 2 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 6 mentions for Merit Medical Systems and 4 mentions for DENTSPLY SIRONA. Merit Medical Systems' average media sentiment score of 1.13 beat DENTSPLY SIRONA's score of 0.37 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Merit Medical Systems 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ICUI or XRAY?

In the previous week, ICU Medical and ICU Medical both had 4 articles in the media. ICU Medical's average media sentiment score of 1.58 beat DENTSPLY SIRONA's score of 0.37 indicating that ICU Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ICU Medical 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive DENTSPLY SIRONA 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor HAE or XRAY?

In the previous week, DENTSPLY SIRONA had 1 more articles in the media than Haemonetics. MarketBeat recorded 4 mentions for DENTSPLY SIRONA and 3 mentions for Haemonetics. DENTSPLY SIRONA's average media sentiment score of 0.37 beat Haemonetics' score of 0.00 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DENTSPLY SIRONA 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

DENTSPLY SIRONA (XRAY) Competitors

$10.09 0.00 (0.00%)

Closing price 06/12/2026 04:00 PM Eastern

Extended Trading

$10.25 +0.16 (+1.63%)

As of 06/12/2026 07:03 PM Eastern

Compare

XRAY vs. COO, MMSI, NVST, ICUI, and HAE

Should you buy DENTSPLY SIRONA stock or one of its competitors? MarketBeat compares DENTSPLY SIRONA with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with DENTSPLY SIRONA include Cooper Companies (COO), Merit Medical Systems (MMSI), Envista (NVST), ICU Medical (ICUI), and Haemonetics (HAE). These companies are all part of the "medical" sector.

How does DENTSPLY SIRONA compare to Cooper Companies?

DENTSPLY SIRONA (NASDAQ:XRAY) and Cooper Companies (NASDAQ:COO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

In the previous week, Cooper Companies had 16 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 20 mentions for Cooper Companies and 4 mentions for DENTSPLY SIRONA. Cooper Companies' average media sentiment score of 0.86 beat DENTSPLY SIRONA's score of 0.37 indicating that Cooper Companies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cooper Companies	8 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

DENTSPLY SIRONA presently has a consensus target price of $13.55, indicating a potential upside of 34.25%. Cooper Companies has a consensus target price of $82.64, indicating a potential upside of 21.75%. Given DENTSPLY SIRONA's higher probable upside, research analysts clearly believe DENTSPLY SIRONA is more favorable than Cooper Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cooper Companies	3 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.41

Cooper Companies has a net margin of 5.57% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-17.06%	18.83%	5.13%
Cooper Companies	5.57%	10.88%	7.27%

95.7% of DENTSPLY SIRONA shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 0.5% of DENTSPLY SIRONA shares are held by insiders. Comparatively, 2.1% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cooper Companies has higher revenue and earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.55	-$598M	-$3.15	N/A
Cooper Companies	$4.09B	3.23	$374.90M	$1.18	57.53

DENTSPLY SIRONA has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

Summary

Cooper Companies beats DENTSPLY SIRONA on 13 of the 17 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Merit Medical Systems?

DENTSPLY SIRONA (NASDAQ:XRAY) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends.

Merit Medical Systems has a net margin of 9.03% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-17.06%	18.83%	5.13%
Merit Medical Systems	9.03%	13.54%	7.94%

Merit Medical Systems has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.55	-$598M	-$3.15	N/A
Merit Medical Systems	$1.52B	2.62	$128.49M	$2.31	28.80

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

DENTSPLY SIRONA has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market.

DENTSPLY SIRONA currently has a consensus price target of $13.55, indicating a potential upside of 34.25%. Merit Medical Systems has a consensus price target of $92.80, indicating a potential upside of 39.49%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than DENTSPLY SIRONA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

In the previous week, Merit Medical Systems had 2 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 6 mentions for Merit Medical Systems and 4 mentions for DENTSPLY SIRONA. Merit Medical Systems' average media sentiment score of 1.13 beat DENTSPLY SIRONA's score of 0.37 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Merit Medical Systems	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Merit Medical Systems beats DENTSPLY SIRONA on 13 of the 16 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Envista?

Envista (NYSE:NVST) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and valuation.

Envista has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market.

Envista has a net margin of 2.41% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
DENTSPLY SIRONA	-17.06%	18.83%	5.13%

Envista currently has a consensus target price of $28.67, indicating a potential upside of 16.80%. DENTSPLY SIRONA has a consensus target price of $13.55, indicating a potential upside of 34.25%. Given DENTSPLY SIRONA's higher probable upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 1.0% of Envista shares are owned by insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, DENTSPLY SIRONA had 4 more articles in the media than Envista. MarketBeat recorded 4 mentions for DENTSPLY SIRONA and 0 mentions for Envista. Envista's average media sentiment score of 0.50 beat DENTSPLY SIRONA's score of 0.37 indicating that Envista is being referred to more favorably in the media.

Company	Overall Sentiment
Envista	Positive
DENTSPLY SIRONA	Neutral

Envista has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.47	$47M	$0.41	59.86
DENTSPLY SIRONA	$3.68B	0.55	-$598M	-$3.15	N/A

Summary

Envista beats DENTSPLY SIRONA on 9 of the 16 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to ICU Medical?

ICU Medical (NASDAQ:ICUI) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, media sentiment, risk and earnings.

In the previous week, ICU Medical and ICU Medical both had 4 articles in the media. ICU Medical's average media sentiment score of 1.58 beat DENTSPLY SIRONA's score of 0.37 indicating that ICU Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ICU Medical	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
DENTSPLY SIRONA	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

ICU Medical has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.23B	1.59	$730K	$1.85	76.86
DENTSPLY SIRONA	$3.68B	0.55	-$598M	-$3.15	N/A

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are held by institutional investors. 2.1% of ICU Medical shares are held by insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

ICU Medical has a net margin of 2.15% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat ICU Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ICU Medical	2.15%	7.50%	3.91%
DENTSPLY SIRONA	-17.06%	18.83%	5.13%

ICU Medical has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market.

ICU Medical currently has a consensus target price of $168.00, suggesting a potential upside of 18.14%. DENTSPLY SIRONA has a consensus target price of $13.55, suggesting a potential upside of 34.25%. Given DENTSPLY SIRONA's higher probable upside, analysts clearly believe DENTSPLY SIRONA is more favorable than ICU Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	3.00
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

ICU Medical beats DENTSPLY SIRONA on 10 of the 15 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Haemonetics?

Haemonetics (NYSE:HAE) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

In the previous week, DENTSPLY SIRONA had 1 more articles in the media than Haemonetics. MarketBeat recorded 4 mentions for DENTSPLY SIRONA and 3 mentions for Haemonetics. DENTSPLY SIRONA's average media sentiment score of 0.37 beat Haemonetics' score of 0.00 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DENTSPLY SIRONA	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Haemonetics has a beta of 0.55, indicating that its share price is 45% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market.

Haemonetics has a net margin of 7.29% compared to DENTSPLY SIRONA's net margin of -17.06%. Haemonetics' return on equity of 27.30% beat DENTSPLY SIRONA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	7.29%	27.30%	9.59%
DENTSPLY SIRONA	-17.06%	18.83%	5.13%

Haemonetics currently has a consensus target price of $77.11, indicating a potential downside of 1.00%. DENTSPLY SIRONA has a consensus target price of $13.55, indicating a potential upside of 34.25%. Given DENTSPLY SIRONA's higher probable upside, analysts plainly believe DENTSPLY SIRONA is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

99.7% of Haemonetics shares are held by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are held by institutional investors. 2.1% of Haemonetics shares are held by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Haemonetics has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.33B	2.65	$97.31M	$2.02	38.56
DENTSPLY SIRONA	$3.68B	0.55	-$598M	-$3.15	N/A

Summary

Haemonetics beats DENTSPLY SIRONA on 12 of the 17 factors compared between the two stocks.

Get DENTSPLY SIRONA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XRAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XRAY vs. The Competition

Export

Metric	DENTSPLY SIRONA	MED/DENTAL Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.02B	$16.03B	$6.53B	$12.05B
Dividend Yield	N/A	1.20%	2.67%	5.66%
P/E Ratio	-3.20	18.58	23.99	24.42
Price / Sales	0.55	2.28	513.41	111.24
Price / Cash	1.68	13.81	27.48	37.92
Price / Book	1.50	3.27	10.73	6.82
Net Income	-$598M	$534.24M	$3.57B	$337.56M
7 Day Performance	-1.66%	-0.17%	0.59%	1.17%
1 Month Performance	0.20%	8.67%	1.54%	3.16%
1 Year Performance	-35.44%	3.15%	25.42%	30.58%

DENTSPLY SIRONA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XRAY DENTSPLY SIRONA	4.2864 of 5 stars	$10.09 flat	$13.55 +34.2%	-35.4%	$2.02B	$3.68B	N/A	14,000
COO Cooper Companies	3.516 of 5 stars	$66.79 -0.8%	$82.64 +23.7%	-2.6%	$13.14B	$4.09B	56.60	15,000	Analyst Downgrade High Trading Volume
MMSI Merit Medical Systems	4.537 of 5 stars	$66.03 +2.4%	$92.80 +40.5%	-28.4%	$3.85B	$1.52B	28.58	7,500	Positive News
NVST Envista	2.4322 of 5 stars	$23.45 +1.5%	$28.83 +22.9%	+33.1%	$3.76B	$2.72B	57.20	12,000
ICUI ICU Medical	3.754 of 5 stars	$137.48 +0.6%	$168.00 +22.2%	+7.7%	$3.41B	$2.23B	74.31	13,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XRAY) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DENTSPLY SIRONA (XRAY) Competitors

XRAY vs. COO, MMSI, NVST, ICUI, and HAE

How does DENTSPLY SIRONA compare to Cooper Companies?

Summary

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Summary

How does DENTSPLY SIRONA compare to Envista?

Summary

How does DENTSPLY SIRONA compare to ICU Medical?

Summary

How does DENTSPLY SIRONA compare to Haemonetics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XRAY vs. The Competition

DENTSPLY SIRONA Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DENTSPLY SIRONA (XRAY) Competitors

XRAY vs. COO, MMSI, NVST, ICUI, and HAE

How does DENTSPLY SIRONA compare to Cooper Companies?

Does the media prefer XRAY or COO?

Do analysts prefer XRAY or COO?

Is XRAY or COO more profitable?

Do institutionals & insiders have more ownership in XRAY or COO?

Which has preferable valuation and earnings, XRAY or COO?

Which has more risk & volatility, XRAY or COO?

Summary

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Is XRAY or MMSI more profitable?

Which has higher earnings and valuation, XRAY or MMSI?

Do insiders & institutionals have more ownership in XRAY or MMSI?

Which has more risk & volatility, XRAY or MMSI?

Do analysts rate XRAY or MMSI?

Does the media prefer XRAY or MMSI?

Summary

How does DENTSPLY SIRONA compare to Envista?

Which has more risk and volatility, NVST or XRAY?

Is NVST or XRAY more profitable?

Do analysts rate NVST or XRAY?

Do institutionals and insiders believe in NVST or XRAY?

Does the media refer more to NVST or XRAY?

Which has higher valuation and earnings, NVST or XRAY?

Summary

How does DENTSPLY SIRONA compare to ICU Medical?

Does the media refer more to ICUI or XRAY?

Which has preferable earnings & valuation, ICUI or XRAY?

Do insiders & institutionals have more ownership in ICUI or XRAY?

Is ICUI or XRAY more profitable?

Which has more risk and volatility, ICUI or XRAY?

Do analysts prefer ICUI or XRAY?

Summary

How does DENTSPLY SIRONA compare to Haemonetics?

Does the media favor HAE or XRAY?

Which has more volatility and risk, HAE or XRAY?

Is HAE or XRAY more profitable?

Do analysts rate HAE or XRAY?

Do institutionals & insiders hold more shares of HAE or XRAY?

Which has preferable earnings and valuation, HAE or XRAY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XRAY vs. The Competition

DENTSPLY SIRONA Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools